by Oliver Pople | Mar 3, 2023 | cost-effectiveness analysis, Health economic modelling, Internship
Insights My summer internship at Symmetron Moving on from education into a new industry can be intimidating, but there are plenty of options for those going through this transition. If you find yourself at this stage of your career, and you are not sure which next...
by Jeanne Armand | Jan 9, 2023 | glossary
Insights HEOR Glossary A Average cost C Cost-benefit analysis Cost-effectiveness analysis Cost-effectiveness threshold H Healthcare system Health economics Health outcome Health state Health technology assessment I Incremental cost Incremental cost-effectiveness ratio...
by Claudia Rinciog, Joseph Whitaker, Sarah Cudworth | Dec 16, 2022 | Cost-effectiveness analysis, Discrete event simulation, Health technology assessment
Insights A cloud computing solution for improving the run-time of individual patient simulation models What’s the longest time you left a health economic model running to complete a probabilistic analysis of 1,000 simulations? One of our senior health economists...
by Kirsten Chalmers | Aug 17, 2022 | Health technology assessment, Healthcare, Market access, NICE
Insights Unmet medical need and market access: enabler or barrier to innovation? Designed to help healthcare stakeholders identify more urgent health needs, the concept of “unmet medical need” is being increasingly applied formally and informally to set priorities...
by Daniela Goncalves Bradley | May 25, 2022 | Clinical trial, Decision analytic, Evidence synthesis, Healthcare
Insights What is qualitative evidence synthesis? Evidence synthesis aggregates all relevant information on a specific topic in order to draw well-informed, evidence-based decisions. It is an essential activity in recommending, providing and evaluating clinical care....
by Kirsten Chalmers | Nov 24, 2021 | Budget impact, Market access
Insights Market access: budget impact analysis What is a budget impact anaylsis? Pressure on healthcare insurers to fund the best available care while keeping within budgetary constraints has made budget impact analysis (BIA) an increasingly important part of any...
by Sam Bryning | Oct 6, 2021 | Cost-effectiveness analysis, Market access
Insights When is a simple model enough? How to handle structural uncertainty in cost-effectiveness models. Sam Bryning, intern at Symmetron: ‘formally accounting for structural uncertainty in cost-effectiveness models makes research and decision making more robust’....
by Frank Grimsey Jones | Aug 21, 2021 | Health economic modelling, Market access
Insights Health economic modelling: a guide for pharmaceutical and medical device companies Health economic modelling is a process for synthesising and comparing the costs and benefits of new (proposed) and existing medicines or devices in order to make decisions...
by Kristen Markus | Aug 13, 2021 | Clinical trial, Evidence generation, Health outcomes, Market access, Medical affairs
Insights Evidence generation and communication in drug development Clinical evidence generation: clinical trials Health researchers continually discover new evidence that deepens our understanding of disease processes and progression. This rapidly evolving knowledge...
by Kristen Markus | Aug 13, 2021 | Evidence synthesis, Health outcomes, Healthcare, Market access
Insights Evidence synthesis for healthcare decision-making What is evidence synthesis? As the pharmaceutical market rapidly evolves to keep pace with patient needs and emerging research, healthcare decision makers must continuously re-evaluate the evidence base that...
